CBL and myelodysplastic syndrome: With mutations found in 1.5% to 5.1% of MDS cases, mutant CBL is thought to significantly impact the development of myeloid malignancies (7). While MDS patients with CBL mutations are not very common, their prognosis is worse than that of patients with wild-type CBL (7).